In a 76‑year‑old man who became hypotensive after taking all four antihypertensive agents, with a recent increase of metoprolol (metoprolol tartrate) from 12.5 mg to 25 mg daily and early‑morning hypoglycemia (glucose 40‑50 mg/dL), how should his blood‑pressure medications be reduced while also managing the hypoglycemia?

Immediate Management: Reduce or Hold Metoprolol and Reassess All Antihypertensives

In this 76-year-old man with acute hypotension after taking all four BP medications and recurrent early-morning hypoglycemia, immediately hold or reduce the metoprolol (recently doubled from 12.5 to 25 mg) and systematically deprescribe at least one other antihypertensive agent, while simultaneously addressing the hypoglycemia by reducing or stopping any sulfonylureas or short-acting insulin.

Algorithmic Approach to Deprescribing

Step 1: Address the Acute Hypotension

• Hold metoprolol immediately – The recent doubling of dose (12.5→25 mg) is the most likely precipitant of acute hypotension 1
• Beta-blockers like metoprolol can cause profound hypotension and bradycardia, especially in elderly patients with hepatic impairment or when combined with other antihypertensives 1
• The FDA label specifically warns about hypotension as a key overdosage sign and recommends vasopressor support if needed 1

Step 2: Systematic Antihypertensive Reduction

Following the polypharmacy deprescribing framework for older adults 2:

Prioritize which medications to reduce/eliminate:

1. Keep ACE inhibitor or ARB – These provide cardiovascular and renal protection, especially given his likely diabetes (on GLP-1 maritide trial) 3
2. Reduce or eliminate the beta-blocker – Unless he has prior MI, active angina, or heart failure with reduced ejection fraction, beta-blockers have not shown mortality benefit as pure BP agents 3
3. Evaluate the other two agents – Consider reducing diuretic dose (can worsen hypotension) or calcium channel blocker based on his specific regimen

Specific deprescribing considerations for elderly patients with intermittent low pressures:

• Patients exhibiting intermittent low pressures, syncope, or falls require BP regimen adjustments with close monitoring 2
• In frail elderly patients, overly aggressive BP control impairs quality of life and can cause serious harm 4

Step 3: Address the Hypoglycemia Problem

The beta-blocker is directly contributing to hypoglycemia risk:

• Metoprolol enhances counter-regulatory hormone responses during hypoglycemia but can delay recovery from hypoglycemia in late phases 5, 6
• Beta-blockers do not mask hypoglycemia awareness but do modify physiological responses 7
• More importantly: The combination of hypoglycemia and beta-blockade creates a dangerous synergy for hypotension

Deintensify diabetes regimen immediately:

• Episodic hypoglycemia (glucose 40-50 mg/dL) is a leading cause of ED admissions in older patients 2
• Stop or reduce sulfonylureas and short-acting insulin first – these are highest-risk medications 2
• Relax glycemic targets in this 76-year-old with significant weight loss and hypoglycemia risk

Step 4: Practical Medication Adjustment Plan

Immediate (today):

• Hold metoprolol completely until BP stabilizes above 100/60 mmHg
• Reduce one other antihypertensive by 50% (preferably diuretic if on one, as volume depletion from 45-lb weight loss may be contributing)
• Check orthostatic vital signs

Within 24-48 hours:

• If BP remains stable off metoprolol, consider permanent discontinuation unless he has specific indication (prior MI, angina, HFrEF)
• If metoprolol is deemed necessary, restart at 12.5 mg daily (the previous dose) only after BP consistently >120/70 mmHg
• Coordinate with endocrinology to adjust diabetes medications for hypoglycemia

Ongoing monitoring:

• Continue 24/7 glucose and BP monitoring (already in place)
• Target BP 130-140/70-80 mmHg in this elderly patient with diabetes 3
• Avoid BP <120/70 mmHg given fall and hypotension risk

Critical Pitfalls to Avoid

1. Don't restart all four medications at once – Reintroduce one at a time if BP rises, waiting 3-5 days between additions
2. Don't ignore the weight loss context – 45 lbs in 4-5 months means his volume status and medication requirements have changed dramatically
3. Don't continue beta-blocker without clear indication – In elderly patients without MI/angina/HFrEF, beta-blockers add hypotension risk without mortality benefit 3
4. Don't overlook drug interactions – If he's on any alpha-2 agonists (tizanidine) or other centrally acting agents with antihypertensives, these create synergistic hypotension 8, 9

Special Considerations for This Patient

The maritide-induced weight loss has fundamentally changed his hemodynamics:

• Reduced body mass decreases cardiac output requirements
• Volume contraction from weight loss reduces BP
• Four antihypertensives that were appropriate at 45 lbs heavier are now excessive

The recent metoprolol increase was inappropriate – Cardiology increased the dose for BP elevation, but this ignored the context of massive weight loss and polypharmacy burden. The correct approach would have been optimizing other agents or addressing volume status, not escalating a beta-blocker in an elderly patient already on three other BP medications.